Sierra Oncology to Participate in Guggenheim Oncology Conference

Rhea-AI Summary

Sierra Oncology, Inc. (NASDAQ: SRRA) will participate in the 4th Annual Guggenheim Oncology Conference, held virtually from February 9-11, 2022. The company's President and CEO, Stephen Dilly, will engage in an analyst-moderated fireside chat on February 10, 2022, at 12:00 pm ET. A replay will be accessible on Sierra's corporate website for 30 days post-conference. Sierra Oncology focuses on delivering targeted therapies for rare cancers, leveraging advanced scientific expertise to transform cancer treatment.

SAN MATEO, Calif.--(BUSINESS WIRE)-- Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the company will participate in the 4^th Annual Guggenheim Oncology Conference being held virtually from February 9 – 11, 2022. President and Chief Executive Officer Stephen Dilly, MBBS, PhD, will participate in an analyst-moderated fireside chat on Thursday, February 10, 2022, at 12:00 pm ET.

A replay of the presentation will be available following the conference on the Investors section of Sierra’s corporate website in the Events & Webcast tab. The replay will be available for approximately 30 days following the presentation.

About Sierra Oncology
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Our team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Together we are transforming promise into patient impact.

For more information, visit www.SierraOncology.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220203005118/en/

Investors

DeDe Sheel

415.732.9828

dsheel@sierraoncology.com

Media

Lauren Musto

615.351.7777

lmusto@sierraoncology.com

Source: Sierra Oncology

FAQ

When will Sierra Oncology participate in the Guggenheim Oncology Conference?

Sierra Oncology will participate in the 4th Annual Guggenheim Oncology Conference from February 9-11, 2022.

Who is speaking at the Guggenheim Oncology Conference for Sierra Oncology?

Stephen Dilly, President and CEO of Sierra Oncology, will participate in a fireside chat.

What date and time is Sierra Oncology's fireside chat during the conference?

The fireside chat is scheduled for February 10, 2022, at 12:00 pm ET.

How can I access the replay of Sierra Oncology's conference presentation?

The replay will be available on Sierra Oncology's corporate website in the Events & Webcast tab for approximately 30 days after the presentation.

What does Sierra Oncology focus on?

Sierra Oncology is committed to delivering targeted therapies for rare cancers.